Search results

Technologies 2

• DROP – A direct-to-consumer molecular diagnostic
  Molecular diagnostics is the fastest growing segment of the global in vitro diagnostics market. There remains a gap, however, in providing this technology directly to consumers in a format that is as cost effective and as simple to use as a lateral flow immunoassay, like glucose and pregnancy tests. Scientists at the Wyss Institute are...
• Paper-based synthetic gene networks as a new diagnostic approach
  With the imminent threat of new pandemics and frequent disease outbreaks exemplified by the recent Ebola and Zika epidemics, there is a growing need for low-cost, easily deployable and simple-to-use diagnostic tools. The Wyss Institute has developed paper-based synthetic gene networks as a next generation diagnostic technology for use in global healthcare crises and patient...

News 4

View all

• Press Release Scientists unveil CRISPR-based diagnostic platform
  April 13, 2017
• Awards Zika diagnostic named finalist for the Katerva Award
  March 24, 2017
• Community Zika test spreads synthetic biology innovation around the world
  December 19, 2016

Multimedia 2

• 

  Audio/Podcast
  Disruptive: Rapid, Low-Cost Detection of Zika & Future Pandemics
  The rapid emergence of the Zika virus on the world stage calls for a detection system that is just as quick. In this episode of Disruptive, Wyss Core Faculty member and MIT professor Jim Collins and University of Toronto Assistant Professor Keith Pardee discuss how they developed a low cost, paper-based diagnostic platform that can...

• 

  Video/Animation
  Detecting Zika: A platform for rapid, low-cost diagnostics
  In this video, a team of collaborators led by Wyss Core Faculty member James Collins discuss a low-cost, paper-based diagnostic system that they developed for detecting specific strains of the Zika virus, with the goal that it could soon be used in the field to easily screen blood, urine, or saliva samples. Credit: Wyss Institute...